The prescription drug with a centuries-old herbal origin is not one medication but an entire class of them, and few examples are more striking than metformin — the second most prescribed medication in the United States, with over 85 million prescriptions written in 2023 alone. Metformin traces its lineage directly to French lilac (*Galega officinalis*), a flowering plant brewed as a tea in medieval Europe to treat what healers recognized as “intense urination,” a telltale symptom of diabetes. That a wildflower remedy from the Middle Ages now anchors modern diabetes management is not a fluke. It reflects a pattern that runs through the entire history of pharmacology. Metformin is far from the only example.
Aspirin descends from willow bark preparations documented in the Ebers Papyrus around 1550 BCE. Colchicine, recently approved as the first anti-inflammatory drug for cardiovascular disease, comes from the autumn crocus described by Greek physicians nearly two thousand years ago. Digoxin, still used to treat heart failure, is literally extracted from foxglove leaves — not synthesized in a lab. Roughly 25 percent of all drugs prescribed worldwide are derived from plants, and of 185 small-molecule drugs approved between 1981 and 2019, 65 percent were derived from or inspired by natural substances. This article traces the journeys of these four medications from folk remedy to pharmacy shelf, examines what their histories reveal about drug discovery, and considers what this botanical heritage means for patients managing conditions like heart disease, diabetes, and cognitive decline.
Table of Contents
- Which Prescription Drugs Have Centuries-Old Herbal Origins?
- From Foxglove to Heart Medication — How Digoxin Bridged Folk Medicine and Cardiology
- Colchicine’s Remarkable Second Act — From Ancient Gout Remedy to Cardiovascular Shield
- What Plant-Derived Drugs Cost Compared to Newer Alternatives
- Why “Natural Origin” Does Not Mean “Safe” — Risks Caregivers Should Know
- The Scale of Botanical Influence on Modern Medicine
- What Botanical Drug History Means for Future Brain Health Treatments
- Conclusion
- Frequently Asked Questions
Which Prescription Drugs Have Centuries-Old Herbal Origins?
The list is longer than most people expect. Metformin’s story begins with *Galega officinalis*, a plant used across medieval Europe not only for diabetes symptoms but also for snake bites and plague. In 1918, the researcher Watanabe confirmed the plant’s ability to lower blood glucose. By the 1920s, scientists had isolated galegine — a less toxic guanidine compound from the plant — and were using it briefly as an antidiabetic agent. The modern drug metformin was first introduced in France in 1957 and did not receive FDA approval in the United States until 1994, nearly eight decades after the plant’s mechanism was scientifically validated. Aspirin’s path is even older. Sumerians and Egyptians were using willow bark for pain relief roughly 3,500 years ago.
Johann Büchner isolated salicin from willow bark at the University of Munich in 1828, and Italian chemist Raffaele Piria derived salicylic acid from salicin a decade later. It was not until 1897 that Bayer chemist Felix Hoffmann synthesized acetylsalicylic acid, the compound we know as aspirin. By 1915, aspirin was available without a prescription — arguably the first modern over-the-counter drug. Today it is considered the most commonly used drug in the world. What separates these botanical medicines from herbal supplements sold at health food stores is the rigor of the journey. Each of these drugs went through isolation of active compounds, chemical refinement, dose standardization, and controlled clinical trials. The plant provided the lead; chemistry and clinical science turned it into something reliable and safe enough to prescribe. That distinction matters enormously for anyone weighing “natural” remedies against proven pharmaceutical treatments, particularly for serious conditions affecting the brain and heart.
From Foxglove to Heart Medication — How Digoxin Bridged Folk Medicine and Cardiology
Few drugs illustrate the bridge between folk remedy and modern prescription as vividly as digoxin. Foxglove (*Digitalis purpurea*) was used in England, Wales, and across Europe as early as the tenth century, primarily as an expectorant and a treatment for epilepsy and swelling. In 1785, English physician William Withering published *An Account of the Foxglove*, documenting 200 cases of successful treatment for dropsy — the old term for edema caused by heart failure. That publication is often cited as a landmark in evidence-based medicine, long before the phrase existed. What makes digoxin unusual among modern drugs is that it is still extracted directly from foxglove leaves in manufacturing rather than being synthesized chemically.
This is partly because the molecule’s structure is complex enough that lab synthesis remains impractical at scale. Digoxin remains a cornerstone therapy for heart failure and atrial fibrillation, conditions that frequently co-occur with vascular dementia and cognitive decline in older adults. However, digoxin carries a significant limitation that anyone in a caregiving role should understand: it has a narrow therapeutic index, meaning the difference between a helpful dose and a dangerous one is small. In elderly patients — precisely the population most likely to need it — kidney function changes can push blood levels of digoxin into toxic territory. Symptoms of digoxin toxicity include confusion, visual disturbances, and nausea, which can easily be mistaken for worsening dementia or other age-related decline. This is one reason why regular blood monitoring is essential for anyone on digoxin, and why caregivers should keep prescribers informed about even subtle changes in cognition or behavior.
